Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.5685
+0.0232 (4.25%)
At close: Oct 2, 2026, 4:00 PM EDT
0.5585
-0.0100 (-1.76%)
After-hours: Oct 2, 2026, 7:39 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $8.74 million as of October 2, 2026. Its market cap has decreased by -34.56% in one year.
Market Cap
8.74M
Enterprise Value
3.72M
1-Year Change
-34.56%
Ranking
Category
Stock Price
$0.57
ChartMarket Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $8.74M, a decrease of -97.87%. That is a compound annual growth rate of -25.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 8.74M | -3.24% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 10.54M |
| CytoMed Therapeutics | 10.52M |
| Moolec Science | 10.38M |
| Moleculin Biotech | 10.25M |
| Immuron | 10.13M |
| KALA BIO | 9.73M |
| Aprea Therapeutics | 9.69M |
| Theriva Biologics | 9.64M |